Invivyd (IVVD) Depreciation and Depletion (2021 - 2024)
Invivyd (IVVD) reported Depreciation and Depletion of $132000.0 for Q3 2024, up 10.92% on a YoY basis from $119000.0 in Q4 2023, and up 3.12% quarter-over-quarter from $128000.0 in Q2 2024.
Invivyd (IVVD) Depreciation and Depletion (2021 - 2024) Analysis & Trends
Invivyd has reported Depreciation and Depletion for 4 years, with the latest figure at $132000.0 in Q3 2024.
- For the quarter ending Q3 2024, Depreciation and Depletion rose 10.92% year-over-year to $132000.0; the trailing twelve-month figure through Sep 2024 stood at $502000.0 (up 29.72% YoY), and the FY2023 full-year result was $480000.0, up 1070.73% from the prior year.
- Depreciation and Depletion for Q3 2024 stood at $132000.0, up from $128000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $132000.0 in Q3 2024, with the low at $1000.0 in Q4 2021.
- Historically, Depreciation and Depletion has averaged $75333.3 across 4 years, with a median of $119500.0 in 2023.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion soared 2900.0% — and 2024, when it gained 1.67%.
- Invivyd's Depreciation and Depletion stood at $1000.0 in 2021, then surged by 2600.0% to $27000.0 in 2022, then surged by 344.44% to $120000.0 in 2023, then climbed by 10.0% to $132000.0 in 2024.
- The last three Depreciation and Depletion figures came in at $132000.0 (Q3 2024), $128000.0 (Q2 2024), and $122000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 121,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |